Peri-implant mucositis. Presence of tooth-root and mandibular implants
Conditions
Interventions
Intervention 1: Intervention group: The group in which reused healing abutment (Dio Pars.Co) is attached to the implant. Intervention 2: Control group: The group in which intact manufacturer healing a
Sponsors
Vice Chancellor for Research and Technology, Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age of the patient should be over 18 Implant treatment should be performed in patients with partial or complete edentulous Bone level implant placement in one stage and obtaining suitable primary stability should be possible. Good patient compliance, reference for follow-up visits and observation of post operation instructions should also be possible.
Exclusion criteria
Exclusion criteria: Patients who have periodontal disease Conditions that affect the immune system such as diabetes and pregnancy The habit of smoking and alcohol or tobacco consumption History of Antibiotics, anti-inflammatory, and immunosuppressive drugs intake three months before the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin-1ß cytokine. Timepoint: Two months after the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) human kits (HANGZHOU EASTBIOPHARM CO.LTD.) for evaluation of interleukin 1ß levels.;Tumor Necrotizing Factor a cytokine. Timepoint: Two months after the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) human kits (HANGZHOU EASTBIOPHARM CO.LTD.) for evaluation of interleukin 1ß levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plaque Index (Ainamo & Bay 1975). Timepoint: 2 months after the intervention. Method of measurement: Observation in such a way that if the plaque is visible on each of the buccal, lingual, mesial or distal surface of healing abutment 0 code and if it is not visible code 1 is assigned.;Bleeding Index (Ainamo & Bay). Timepoint: 2 months after the intervention. Method of measurement: Observation in such a way that if bleeding on probing is visible on each of the buccal, lingual, mesial or distal surface of healing abutment 0 code and if it is not visible code 1 is assigned. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazila Lashkarizadeh
Kerman University of Medical Sciences
Outcome results
None listed